Seminars in Oncology Nursing最新文献

{"title":"Oncology Advanced Practice Nurses' Memorable Patient Care Experiences: A Qualitative Analysis.","authors":"Abigail G Cohen, Vanessa Battista, Judith Paice, Betty R Ferrell","doi":"10.1016/j.soncn.2025.151910","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151910","url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of this study was to describe oncology advanced practice nurses' (APRNs) experiences caring for memorable patients, the meaning derived from patients' experiences and the influence patients have had on their careers. This study builds on work describing the meaning of oncology nursing practice.</p><p><strong>Methods/results: </strong>Oncology APRNs (N=66) participating in an NCI funded ELNEC course responded to 3 open-ended prompts/questions: (1) Share a story about a memorable patient, (2) Why do you think the memory of this patient is meaningful to you? (3) How do you think caring for this patient has influenced your nursing career? A thematic, qualitative analysis of their responses identified several key themes including: (1) Lessons learned: Usually profound, occasionally resulting in career altering impact. (2) Admiration: Admiration for patients' kindness, grace, strength, hope and courage through terminal illness. (3) Delivery of high-quality palliative care: The foundation for deep connections and mutually beneficial relationships between APRNs and patients. (4) Challenges: Clinical scenarios involving APRNs feeling like they failed; staff distress, trauma, or grief.</p><p><strong>Conclusions: </strong>Oncology nurses described early nursing career experiences of patients as the greatest teachers and shared invaluable and transformative lessons learned about what it means to be human in the face of serious illness.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151910"},"PeriodicalIF":2.3,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144188546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Taste Alterations in Pediatric Oncology Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.","authors":"Eyşan Hanzade Savaş, Aylin Akça Sümengen, Ayşe Ay, Münevver Erkul, İlçim Ercan Koyuncu, Gökçe Naz Çakır, Remziye Semerci","doi":"10.1016/j.soncn.2025.151909","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151909","url":null,"abstract":"<p><strong>Background and aim: </strong>Taste alterations are common yet often overlooked side effects in pediatric oncology patients undergoing hematopoietic stem cell transplantation (HSCT), impacting nutrition and quality of life. This systematic review and meta-analysis aimed to synthesize evidence on the prevalence, characteristics, and treatment phase-specific changes in taste perception among these patients.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted across 6 academic databases-PubMed, Cochrane Library, MEDLINE (via Ovid), Scopus, Web of Science, and CINAHL-covering publications up to February 13, 2025. Data extraction and quality appraisal were independently performed by 2 reviewers using the QualSyst tool (The Standardized Quality Assessment Criteria for Evaluating Primary Research Articles from Various Fields) for quantitative studies. This systematic review was registered in PROSPERO (ID: CRD42025646761) and conducted by the PRISMA guidelines.</p><p><strong>Results: </strong>The included studies involved 1,403 pediatric patients aged 0.4-29.9 years. Taste alterations were prevalent, particularly during the early post-transplant phases, with symptoms including dysgeusia, changes in taste thresholds, and reduced sensitivity to sweet and salty tastes. The meta-analysis revealed an event rate of 0.457 (95% CI: 0.330-0.590), which was not statistically significant (P = .529).</p><p><strong>Conclusion: </strong>Taste alterations are frequent in pediatric HSCT patients, varying by treatment phase and assessment method. Early identification and management strategies are essential to mitigate their impact on nutrition and quality of life. Further research is needed to standardize assessment tools and intervention strategies.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151909"},"PeriodicalIF":2.3,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144163713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acceptability of an Electronic Patient-Reported Outcomes-Based Model of Care to Monitor Symptoms Related to Cancer Treatment with Immune Checkpoint Inhibitors: Results from the IePRO Randomized Controlled Trial.","authors":"André Manuel da Silva Lopes, Stellio Giacomini, Ambily Ulahannan, Celia Darnac, Sebastien Bugeia, Garance Gutknecht, Sara Colomer-Lahiguera, Gilliosa Spurrier-Bernard, Sofiya Latifyan, Alfredo Addeo, Olivier Michielin, Manuela Eicher","doi":"10.1016/j.soncn.2025.151903","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151903","url":null,"abstract":"<p><strong>Objectives: </strong>This study analyzed the acceptability of an electronic patient-reported outcomes measures-based model of care (IePRO MoC) and the usability of its complementary ePROM mobile app to monitor and manage symptoms related to immune checkpoint inhibitors. In this MoC, symptoms reported by patients treated at an outpatient clinic were reviewed by oncology triage nurses who provided symptom management interventions by telephone.</p><p><strong>Methods: </strong>As part of a larger intervention trial (ClinicalTrials.gov.NCT05530187) we conducted an abductive, semantic thematic analysis through semistructured interviews of patients participating in the intervention arm. Acceptability was deduced from Sekhon et al's (2017) Theoretical Framework of Acceptability completed with inductively generated themes. Usability analysis was guided by the mHealth App Usability Questionnaire's domains by Zhoul et al (2019).</p><p><strong>Results: </strong>A total of 17 interviews were performed. The IePRO MoC was reported to be an acceptable intervention. Patients expressed feeling safe and empowered due to continuous monitoring and timely support from nurses. Personalized support motivated patients to use the MoC throughout treatment. Some questioned the predefined response options of the app, and the standardized approach regarding notifications and monitoring requirements. Despite high app usability, some expressed discomfort from being frequently reminded of their illness and being confronted with questions about their sexuality and other intimate themes.</p><p><strong>Conclusions: </strong>The feedback loop between patients and nurses facilitated the acceptability of the IePRO MoC. The app's usability further facilitated adherence to the MoC. A more personalized approach regarding the frequency of assessments and the way symptoms are conveyed is recommended to decrease discomfort and support the implementation of similar MoCs in the future.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151903"},"PeriodicalIF":2.3,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144144307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating Remote Symptom Monitoring, Person-Centered Analytics, and Artificial Intelligence to Advance Precision Health Symptom Science in Oncology.","authors":"Rachel A Pozzar","doi":"10.1016/j.soncn.2025.151901","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151901","url":null,"abstract":"<p><strong>Objectives: </strong>To summarize the relevance of remote symptom monitoring, person-centered statistical analyses, and artificial intelligence to precision health symptom science in oncology; and propose ways in which these three approaches can be integrated to further advance the field.</p><p><strong>Methods: </strong>The following commentary was adapted from a talk delivered at the Symptom Science Experts Meeting in October 2023 at the University of Lausanne, Switzerland. The commentary and talk were informed by an informal review of recent literature in precision health oncology symptom science.</p><p><strong>Results: </strong>Several remote symptom monitoring interventions have demonstrated potential to reduce disease- and treatment-related symptom burden and improve health outcomes in patients with cancer. Data collected passively by wearable and sensor technologies are also being used to characterize patients' health status. Person-centered statistical analyses have identified interindividual variability in the symptom experiences of patients with cancer. Together with artificial intelligence-based approaches, these analyses have identified factors associated with relatively adverse symptom experiences. Future directions for the field include integrating these approaches to optimize clinical resource allocation, tailor symptom management in real-time, and advance scientific knowledge of the symptom experience.</p><p><strong>Conclusions: </strong>Integrating remote symptom monitoring, person-centered statistical analyses and artificial intelligence may provide deeper insights into how patients with cancer experience symptoms.</p><p><strong>Implications for nursing practice: </strong>Findings from research that uses remote symptom monitoring, person-centered statistical analyses, and artificial intelligence may enhance clinicians' ability to deliver personalized symptom management interventions.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151901"},"PeriodicalIF":2.3,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Different Level and Difficulties with Financial Burden in Multiple Myeloma Patients and Caregivers: A Dyadic Qualitative Study.","authors":"YoungJu Park, Sooyeon Kim, Nayeon Kim, Jeong Hyun Park, Garam Bang, Danbee Kang, Sang Eun Yoon, Kihyun Kim, Juhee Cho, Seok Jin Kim","doi":"10.1016/j.soncn.2025.151848","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151848","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to explore the multifaceted financial burden experienced by patients with multiple myeloma (MM) and their caregivers, focusing on direct and indirect costs, as well as variability and discordance in perceived financial burdens.</p><p><strong>Methods: </strong>A dyadic qualitative study was conducted with 40 patient-caregiver pairs recruited from a tertiary hospital in Seoul, Korea. Semistructured interviews were used to explore participants' experiences with financial burden, and thematic analysis was performed to identify key themes. Quantitative analyses were also conducted to examine clinical and sociodemographic data.</p><p><strong>Results: </strong>A total of 80 participants (41 patients and 39 caregivers) were enrolled. Patients had a median age of 70 years, with a median time since diagnosis of 24 months. Financial burdens were categorized into direct medical and nonmedical costs, as well as indirect costs such as income loss. Variability in financial burden was influenced by factors such as patient age, disease state, and financial stability. Caregivers, particularly adult children, reported a broader perspective on the long-term financial impact, while patients focused on immediate costs. Discordance in perceived burden was evident in over 75% of dyads, with caregivers often perceiving a heavier burden than patients.</p><p><strong>Conclusions: </strong>The financial burden of MM is complex and evolves over time, with notable differences between patient and caregiver perceptions. Caregivers bear significant nonmedical and indirect costs, while patients emphasize immediate financial concerns. These findings highlight the need for family-wide financial counseling and support to address the evolving nature of financial toxicity throughout the disease journey.</p><p><strong>Implications for nursing practice: </strong>Nurses play a vital role in addressing the financial burdens of MM patients and caregivers. They should facilitate open communication to align expectations, provide financial counseling, and advocate for family-centered care. By supporting tailored interventions and resource access, nurses can help reduce financial burden, improving the overall well-being of patients and their families.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151848"},"PeriodicalIF":2.3,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Use of Biomarkers in Precision Health Symptom Science-Opportunities and Challenges.","authors":"Carolyn S Harris, Yvette P Conley, Jinbing Bai, Marilyn J Hammer","doi":"10.1016/j.soncn.2025.151886","DOIUrl":"https://doi.org/10.1016/j.soncn.2025.151886","url":null,"abstract":"<p><strong>Objectives: </strong>Precision health symptom science applies person-centered approaches to elucidate interindividual differences in patients' symptom experiences and incorporates omics methods with social, societal, and environmental determinants of health to develop symptom management strategies. By filling scientific gaps related to patients' symptom experiences and their underlying mechanisms, interventions can be developed to improve quality of life and outcomes. The purposes of this article are to describe symptom phenotype development; review analytical approaches to identify a symptom phenotype; and discuss common and emerging methods for biomarker discovery and their implications in precision health symptom science.</p><p><strong>Methods: </strong>Peer-reviewed research studies, review articles, and scientific expertise were synthesized to provide a broad overview of several methods of biomarker discovery and their implications for precision health symptom science.</p><p><strong>Results: </strong>Approaches to symptom phenotype development and analytical methods for phenotype identification were reviewed. Common (ie, genomic, epigenomic, transcriptomic, proteomic, metabolomic, microbiome) and emerging (ie, polygenic risk scores, microRNA, epigenetic clocks, allostatic load, wearables) methods for biomarker discovery were described. Each method provides unique information to improve our understanding of the complex biological processes that underlie symptoms and may be used for risk prediction, screening, surveillance, and treatment response.</p><p><strong>Conclusions: </strong>While the exemplar approaches to conducting precision health symptom science were shared through an oncology lens, they are generalizable across acute and chronic conditions.</p><p><strong>Implications for nursing practice: </strong>Symptom biomarker identification is inherently complex and the methods for biomarker collection, processing, measurement, and analysis are continually evolving. Therefore, symptom scientists need to form transdisciplinary teams with experts in omics methodologies and bioinformatics. Despite the challenges, symptom scientists are well suited to lead the way in precision health symptom science to reduce symptom burden and improve quality of life among patients with various chronic conditions.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151886"},"PeriodicalIF":2.3,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144032463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Greater Symptom Burden and Poorer Quality of Life Outcomes Are Associated With The Co-Occurrence of Anxiety and Depression During Cancer Chemotherapy","authors":"Alejandra Calvo-Schimmel ,&nbsp;Marilyn J. Hammer ,&nbsp;Yvette P. Conley ,&nbsp;Steven M. Paul ,&nbsp;Bruce A. Cooper ,&nbsp;Joosun Shin ,&nbsp;Carolyn Harris ,&nbsp;Lisa Morse ,&nbsp;Jon D. Levine ,&nbsp;Christine Miaskowski","doi":"10.1016/j.soncn.2025.151809","DOIUrl":"10.1016/j.soncn.2025.151809","url":null,"abstract":"<div><h3>Objectives</h3><div>Anxiety and depression are common symptoms in oncology patients undergoing chemotherapy. Study purpose was to evaluate for differences in severity of common symptoms (ie, fatigue, energy, sleep disturbance, cognitive function, pain) and quality of life (QOL) outcomes among three subgroups of oncology outpatients with distinct joint anxiety and depression profiles.</div></div><div><h3>Methods</h3><div>Oncology outpatients (N = 1328) completed measures of state anxiety and depression, six times over two cycles of chemotherapy. Latent profile analysis was done to identify subgroups of patients with distinct joint state anxiety AND depression profiles. Patients completed measures of trait anxiety, morning and evening fatigue, morning and evening energy, sleep disturbance, cognitive function, and pain, as well as generic and disease-specific measures of QOL at enrollment. Differences among the classes in symptom severity scores and QOL scores were evaluated using parametric and non-parametric tests.</div></div><div><h3>Results</h3><div>Three distinct joint anxiety AND depression profiles were identified and named: Low Anxiety and Low Depression (57.5%, Both Low), Moderate Anxiety and Moderate Depression (33.7%, Both Moderate), and High Anxiety and High Depression (8.8%, Both High). All of the symptom severity scores showed a “dose-response effect” (ie, as the joint anxiety AND depression profiles worsened, the severity of all of the symptoms increased). Likewise, for both the general and disease-specific QOL (except spiritual well-being) measures, all of the scores decreased as the joint anxiety AND depression profiles worsened. Compared to the Both Low classes, the other two classes reported lower scores for the spiritual well-being domain.</div></div><div><h3>Conclusions</h3><div>More than 40% of patients receiving chemotherapy experience moderate to high levels of both anxiety AND depression. These patients report an extremely high symptom burden and significant decrements in all domains of QOL.</div></div><div><h3>Implications for Nursing Practice</h3><div>Clinicians need to perform comprehensive assessments of depression and anxiety and other common symptoms and QOL outcomes during chemotherapy. In addition, referrals for targeted interventions are needed to manage multiple symptoms and improve patients’ QOL.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151809"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143426624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Readiness to Implement Novel SACT: Tumor-Infiltrating Lymphocyte Therapy","authors":"Linda Gomm","doi":"10.1016/j.soncn.2025.151841","DOIUrl":"10.1016/j.soncn.2025.151841","url":null,"abstract":"<div><h3>Objectives</h3><div>Adoptive cell therapy using tumor-infiltrating lymphocyte (TIL) therapy has demonstrated promising results in clinical trials. Recognizing the growing potential of cell therapies for solid tumors, oncology services need to prepare for an increasing number of trials and, in the near future, optimize patient access to TIL. Consultation with clinical trials professionals in England, however, highlighted low organizational readiness and significant knowledge gaps for use of adoptive cell therapy. The aim of this discussion paper is to provide guidance about the role of the nurse in the delivery of TIL therapy.</div></div><div><h3>Methods</h3><div>Guidance was written based on peer-reviewed literature and best practice guidelines between 2006 and 2024 identified through electronic database searches on PubMed, CINAHL, and MEDLINE and expert experience of managing patients in clinical trials who are receiving TIL.</div></div><div><h3>Results</h3><div>TIL therapy is set to transform current care pathways with treatments that can potentially induce long-lasting tumor responses. There are, however, numerous challenges for successful and safe implementation of TIL therapy in practice. Nurses have a central role in coordinating the safe delivery and patient care of patients receiving TIL therapy. Nurses need knowledge and understanding about the regulatory processes and extensive treatment pathways involved whilst also managing novel side effects and patient expectations.</div></div><div><h3>Conclusions</h3><div>TIL therapy requires a specialist team to safely deliver these complex treatments and support colleagues nursing patients receiving TIL therapy. Specialist knowledge and skills and close coordination is required to ensure a smooth process from patient referral, product ordering, manufacturing, storage, and administration of the treatment to the patient.</div></div><div><h3>Implications for Nursing Practice</h3><div>Organizations planning to initiate TIL therapy should review their infrastructure, identify and address specialist knowledge and skills needs of oncology professionals, and seek guidance and support from expert teams. There needs to be a robust governance structure in place and ensure all healthcare professionals involved are trained and educated on a high level on how to care for these patients.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151841"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143411503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pilot Testing a Peer-Led Self-Management Program for Women After Breast Cancer","authors":"Karin Ribi ,&nbsp;Franziska Schmidt ,&nbsp;Jörg Haslbeck ,&nbsp;Corinne Urech ,&nbsp;Karin Holm ,&nbsp;Manuela Eicher ,&nbsp;COSS Pilot Study Group","doi":"10.1016/j.soncn.2025.151814","DOIUrl":"10.1016/j.soncn.2025.151814","url":null,"abstract":"<div><h3>Background</h3><div>Different approaches exist to support self-management in breast cancer (BC) survivors. The aim of this project was to cocreate a new version of an existing peer-led program to meet the needs of BC survivors in Switzerland. In a pilot study, the preliminary efficacy in terms of self-management skills and symptom burden and the feasibility of implementing it in two Swiss university hospitals was assessed.</div></div><div><h3>Methods</h3><div>A prospective nonequivalent pretest-posttest control group design with two consecutive cohorts of women with early-stage BC who had completed primary treatment was applied. BC survivors (peers) led the 7-week course of weekly small-group sessions of 2.5 to 3 hours. The primary outcome was change in self-management skills; secondary outcomes included change in self-efficacy, symptom burden, and health literacy. Between-group changes were assessed using the Mann–Whitney <em>U</em> or <em>X</em>² test, individual changes using the Reliable Change Index. Feasibility was assessed using qualitative methods.</div></div><div><h3>Results</h3><div>Of the 95 BC survivors screened for inclusion criteria, 68 were eligible, 18 agreed to participate in the control group and 20 in the intervention group. No significant differences were found between the groups for any of the outcomes. Individual changes in self-management skills were noted in both groups. Several issues related to course delivery and feasibility were identified.</div></div><div><h3>Conclusions</h3><div>The current form of the program did not fully meet the needs of BC survivors, and implementation into the clinical care pathway appeared to be challenging. The program may benefit from providing the possibility of spontaneous interaction and discussion and considering elements of e-health interventions.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151814"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Barriers and Facilitators to Physical Activity Participation Among Colorectal Cancer Survivors: A Mixed-Method Systematic Review","authors":"Jiayu Mao ,&nbsp;Yi Zhang ,&nbsp;Xiaoke Qiu ,&nbsp;Can Wang ,&nbsp;Xueli Yang ,&nbsp;Qiuping Li","doi":"10.1016/j.soncn.2025.151811","DOIUrl":"10.1016/j.soncn.2025.151811","url":null,"abstract":"<div><h3>Objectives</h3><div>Physical activity (PA) is essential in cancer rehabilitation. Worryingly, PA compliance among colorectal cancer (CRC) survivors is relatively poor, and the barriers and facilitators of PA participation in this population are poorly understood. This review aimed to identify the barriers and facilitators of PA participation among CRC survivors and apply the Capability-Opportunity-Motivation-Behavior (COM-B) model to analyze and categorize these factors.</div></div><div><h3>Methods</h3><div>A mixed-method systematic review was conducted using six electronic databases (Embase, Medline, PubMed, Scopus, Web of Science, and Chinese National Knowledge Infrastructure) to conduct literature search. The searches were conducted from the inception of databases till May 2024, and eligible studies were limited to English or Chinese. The mixed methods appraisal tool (MMAT) was utilized to perform quality assessment, and the convergent integrated approach and descriptive analysis were used for data synthesis and analysis.</div></div><div><h3>Results</h3><div>This review included 32 studies (seven qualitative, 24 quantitative, and one mixed-method), and no studies were eliminated due to quality. According to the COM-B model, cancer-related symptoms, time constraints, and lack of motivation or interest were the main barriers to PA participation among CRC survivors. The main facilitators of PA participation for CRC survivors included improvement in cancer-related symptoms, enough social support from family and friends, and perceived benefits of PA.</div></div><div><h3>Conclusions</h3><div>This review comprehensively identified the unique barriers and facilitators to PA participation among CRC survivors based on the COM-B model. Future research should consider these barriers and facilitators and develop effective PA interventions to increase PA compliance among CRC survivors.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151811"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}